Potential Link Between Regular Opioid Use and Increased Dementia Risk
New research associates regular opioid consumption with a higher risk of dementia and brain volume reduction, emphasizing cautious opioid prescribing for chronic pain management.
Recent research published in Alzheimer's & Dementia reveals a significant association between consistent opioid use and a heightened risk of developing dementia, especially vascular dementia. Led by Dr. Sha Feng from the Shenzhen Institute of Advanced Technology and collaborating with experts from Massachusetts Veterans Home and the University of Pennsylvania, the study highlights critical insights into how opioids may influence cognitive health.
Chronic non-cancer pain (CNCP), a condition persisting for over three months unrelated to cancer, saw widespread opioid prescriptions starting in the mid-1990s. This increase has raised concerns over dependence, misuse, and potential neurological impacts. Existing evidence suggests that opioids can alter the brain's endogenous opioid system and impair regions such as the hippocampus, which are vital for cognitive function.
The study analyzed data from 197,673 UK Biobank participants aged between 37 and 73 years over an average follow-up period of nearly 14 years. Employing advanced statistical models to control for confounding factors, researchers found that individuals who regularly used opioids faced a 20% higher overall risk of developing dementia compared to non-opioid analgesic users. Those on high-potency opioids faced an even greater risk, exceeding 70%. Conversely, individuals taking non-opioid painkillers showed dementia risk comparable to those not using opioids.
Neuroimaging assessments further revealed that regular, strong opioid use was associated with reductions in total brain volume, white matter, and hippocampal size—regions crucial for memory and cognition. Additionally, regular opioid use was linked to decreased fluid intelligence, although no significant decline was observed in prospective memory.
These findings underscore the importance of evaluating opioid potency and cumulative exposure when considering risks related to cognitive decline. The research underscores the necessity for cautious opioid prescribing, especially for long-term pain management, to mitigate potential adverse effects on brain health.
Source: https://medicalxpress.com/news/2025-07-regular-opioid-dementia.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Advancements in 3D-Printed Lung Models for Better Disease Study and Treatment
Researchers are developing 3D-printed lung models that could revolutionize disease study and personalized treatment, paving the way for improved therapies and potential lung regeneration.
New Insights into PAD2 Enzyme's Role in Pancreatic Cancer Progression
Scientists have identified the enzyme PAD2 as a crucial factor in pancreatic cancer growth, suggesting that targeting PAD2 could lead to new epigenetic treatments for PDAC.
Targeting Enzyme Activity Offers Hope for Parkinson's Disease Treatment
Innovative research reveals that inhibiting the overactive enzyme LRRK2 can protect neurons and potentially reverse early Parkinson's disease cellular damage, offering new hope for treatment.
Risks of Nighttime Mouth Taping Promoted on Social Media for Sleep Breathing Issues
A recent review warns that the trendy practice of mouth taping during sleep, promoted on social media, may be ineffective and pose serious health risks, including asphyxiation, especially for those with nasal obstructions.